Axel Cangas/LinkedIn
Jul 19, 2026, 16:58
Axel Cangas: Exploring the Future of Hemophilia Care at ISTH 2026
Axel Cangas, Hematology and Immunology Unit Head at Roche México, shared a post on LinkedIn:
”Thrilled to be at International Society on Thrombosis and Haemostasis (ISTH) 2026 engaging with global experts on the incredible scientific advancements redefining haemophilia care.
It has been inspiring to see Roche’s deep, long-term commitment to this community.
We remain dedicated to standing alongside patients, families, and healthcare professionals for generations to come.”
Stay updated with Hemostasis Today.
-
Sep 4, 2026, 02:44Ahmed Kotb: Emergency Management of Critical Bleeding in ITP
-
Sep 4, 2026, 02:30Mario Jimenez: KDIGO 2026 – A More Proactive Approach to IV Iron in Hemodialysis
-
Sep 4, 2026, 02:18Edgardo Alania: Edoxaban in Intracranial Haemorrhage Survivors with AF
-
Sep 3, 2026, 20:33Jennifer Weinstein: Happy to Share Our New Work on the Patient Experience in VWD at the NBDF Conference
-
Sep 3, 2026, 20:31Guillaume Courbon: New Publication on Erythroid-Produced FGF23 and Its Role in Anemia
-
Sep 3, 2026, 20:30Phuong Khanh Morrow: FDA Approval Marks an Important Step Forward for the PV Community
-
Sep 3, 2026, 20:29Sarah Robins: Happy to Share This Portrait Film I Voiced for the NNHHF
-
Sep 3, 2026, 20:27Mireille Muller: Europe Needs More Plasma Donors
-
Sep 3, 2026, 17:54Tareq Abadl: Extravascular Hemolysis The High-Yield Guide